000 01449 a2200445 4500
005 20250516090449.0
264 0 _c20120910
008 201209s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2012.03.108
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUrbahns, Klaus
245 0 0 _aTetrahydro-naphthols as orally available TRPV1 inhibitors.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cMay 2012
300 _a3408-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aBiological Availability
650 0 4 _aNaphthols
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aTRPV Cation Channels
_xantagonists & inhibitors
700 1 _aYura, Takeshi
700 1 _aGupta, Jang B
700 1 _aTajimi, Masaomi
700 1 _aFujishima, Hiroshi
700 1 _aMasuda, Tsutomu
700 1 _aYamamoto, Noriyuki
700 1 _aIkegami, Yuka
700 1 _aMarumo, Makiko
700 1 _aYasoshima, Kayo
700 1 _aYoshida, Nagahiro
700 1 _aMoriwaki, Toshiya
700 1 _aMadge, David
700 1 _aChan, Fiona
700 1 _aMogi, Muneto
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 22
_gno. 10
_gp. 3408-11
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2012.03.108
_zAvailable from publisher's website
999 _c21723754
_d21723754